Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging
Clinical trial NCT02266966 · COMPLETED
Trial details
- NCT number
- NCT02266966
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-09-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.